2007 focused update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention: a report of the American College of Cardiology/American …

SB King III, SC Smith Jr, JW Hirshfeld Jr, AK Jacobs… - Circulation, 2008 - Am Heart Assoc
Interventions. Copies: This document is available on the World Wide Web sites of the
American College of Cardiology (www. acc. org), American Heart Association (my …

Dosing clopidogrel based on CYP2C19 genotype and the effect on platelet reactivity in patients with stable cardiovascular disease

JL Mega, W Hochholzer, AL Frelinger, MJ Kluk… - Jama, 2011 - jamanetwork.com
Context Variants in the CYP2C19 gene influence the pharmacologic and clinical response
to the standard 75-mg daily maintenance dose of the antiplatelet drug clopidogrel. Objective …

Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis

F Andreotti, B Rocca, S Husted, RA Ajjan… - European heart …, 2015 - academic.oup.com
Contemporary medicine is shifting towards person rather than disease-oriented care. 1 With
increasing life expectancy and the ageing of baby boomers, the proportion over 60 years is …

Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial.

S Yusuf, SR Mehta, S Chrolavicius… - JAMA: Journal of …, 2006 - search.ebscohost.com
Context Despite many therapeutic advances, mortality in patients with acute ST-segment
elevation myocardial infarction (STEMI) remains high. The role of additional antithrombotic …

Diagnosis and management of acute coronary syndrome: an evidence-based update

JN Smith, JM Negrelli, MB Manek… - The Journal of the …, 2015 - Am Board Family Med
Acute coronary syndrome (ACS) describes the range of myocardial ischemic states that
includes unstable angina, non-ST elevated myocardial infarction (MI), or ST-elevated MI …

Antiplatelet therapies for the treatment of cardiovascular disease

AD Michelson - Nature Reviews Drug Discovery, 2010 - nature.com
Antiplatelet therapy has been successful in reducing mortality and morbidity in acute
myocardial infarction. Recent advances in understanding the molecular basis of the role of …

[HTML][HTML] I Diretriz de ressuscitação cardiopulmonar e cuidados cardiovasculares de emergência da Sociedade Brasileira de Cardiologia

MM Gonzalez, S Timerman… - Arquivos brasileiros de …, 2013 - SciELO Brasil
Esta edição traz as Diretrizes Brasileiras sobre o Manejo da Ressuscitação Cardiopulmonar
(RCP). Embora a ressuscitação tenha uma longa história que remonta aos tempos bíblicos …

Acute coronary care in the elderly, part II: ST-segment–elevation myocardial infarction: a scientific statement for healthcare professionals from the American Heart …

KP Alexander, LK Newby, PW Armstrong, CP Cannon… - Circulation, 2007 - Am Heart Assoc
Background—Age is an important determinant of outcomes for patients with acute coronary
syndromes. However, community practice reveals a disproportionately lower use of …

[HTML][HTML] Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial

JJF Belch, J Dormandy… - Journal of vascular …, 2010 - Elsevier
OBJECTIVE: Dual antiplatelet therapy with clopidogrel plus acetylsalicylic acid (ASA) is
superior to ASA alone in patients with acute coronary syndromes and in those undergoing …

Diabetes and antiplatelet therapy in acute coronary syndrome

JL Ferreiro, DJ Angiolillo - Circulation, 2011 - Am Heart Assoc
Cardiovascular disease, particularly coronary artery dis-ease resulting from accelerated
atherosclerosis, is the leading cause of morbidity and mortality in patients with diabetes …